OBJECTIVE: To characterize the risk and predictors of growth during observation of vestibular schwannomas (VS). STUDY DESIGN: Retrospective case series. SETTING: Single academic, tertiary care center. PATIENTS: Five hundred sixty-four consecutive VS patients who underwent at least two magnetic resonance imaging (MRI) studies before intervention. INTERVENTION(S): Serial MRI studies. MAIN OUTCOME MEASURE(S): Tumor growth, defined as a ≥2 mm increase in the maximum tumor diameter between consecutive MRI studies, or between the first and last study. RESULTS: A total of 1296 patients (1995-2015) with VS were identified. Of those, 564 patients (median age 59.2 years; 53.5% female) were initially observed and underwent multiple MRI studies (median follow-up 22.9 months, interquartile range [IQR] 11.7-42.7). The median maximum tumor diameter at presentation was 1.00 cm (IQR 0.6-1.51 cm). In all, 40.8% of tumors demonstrated growth and 32.1% underwent intervention (21.5% microsurgery, 10.5% radiation) during the surveillance period. Multivariable Cox regression analysis showed that for each tumor, the risk of growth or intervention was significantly increased for larger initial VS diameters (HR = 2.22; 95% CI: 1.90-2.61) and when disequilibrium was a presenting symptom (HR = 1.70; 95% CI: 1.30-2.23). Patient age, sex, aspirin use, and presenting symptoms of asymmetric hearing loss, tinnitus, and vertigo were not associated with tumor growth. CONCLUSION: To date, this is the largest series of observed VS reported in the literature. Risk of VS growth is significantly increased among patients who present with larger tumors and who have concomitant disequilibrium.IRB:: 151481. DEFINE PROFESSIONAL PRACTICE GAP AND EDUCATIONAL NEED: No cohort with this sample size has assessed vestibular schwannoma growth rates in conjunction with this number of variables. LEARNING OBJECTIVE: To characterize vestibular schwannoma growth rates and predictors of growth.
OBJECTIVE: To characterize the risk and predictors of growth during observation of vestibular schwannomas (VS). STUDY DESIGN: Retrospective case series. SETTING: Single academic, tertiary care center. PATIENTS: Five hundred sixty-four consecutive VS patients who underwent at least two magnetic resonance imaging (MRI) studies before intervention. INTERVENTION(S): Serial MRI studies. MAIN OUTCOME MEASURE(S): Tumor growth, defined as a ≥2 mm increase in the maximum tumor diameter between consecutive MRI studies, or between the first and last study. RESULTS: A total of 1296 patients (1995-2015) with VS were identified. Of those, 564 patients (median age 59.2 years; 53.5% female) were initially observed and underwent multiple MRI studies (median follow-up 22.9 months, interquartile range [IQR] 11.7-42.7). The median maximum tumor diameter at presentation was 1.00 cm (IQR 0.6-1.51 cm). In all, 40.8% of tumors demonstrated growth and 32.1% underwent intervention (21.5% microsurgery, 10.5% radiation) during the surveillance period. Multivariable Cox regression analysis showed that for each tumor, the risk of growth or intervention was significantly increased for larger initial VS diameters (HR = 2.22; 95% CI: 1.90-2.61) and when disequilibrium was a presenting symptom (HR = 1.70; 95% CI: 1.30-2.23). Patient age, sex, aspirin use, and presenting symptoms of asymmetric hearing loss, tinnitus, and vertigo were not associated with tumor growth. CONCLUSION: To date, this is the largest series of observed VS reported in the literature. Risk of VS growth is significantly increased among patients who present with larger tumors and who have concomitant disequilibrium.IRB:: 151481. DEFINE PROFESSIONAL PRACTICE GAP AND EDUCATIONAL NEED: No cohort with this sample size has assessed vestibular schwannoma growth rates in conjunction with this number of variables. LEARNING OBJECTIVE: To characterize vestibular schwannoma growth rates and predictors of growth.
Authors: Matthew L Carlson; Elizabeth B Habermann; Amy E Wagie; Colin L Driscoll; Jamie J Van Gompel; Jeffrey T Jacob; Michael J Link Journal: Otolaryngol Head Neck Surg Date: 2015-06-30 Impact factor: 3.497
Authors: Gian Gaetano Ferri; Giovanni Carlo Modugno; Antonio Pirodda; Antonio Fioravanti; Fabio Calbucci; Alberto Rinaldi Ceroni Journal: Laryngoscope Date: 2008-06 Impact factor: 3.325
Authors: Maria Peris-Celda; Christopher S Graffeo; Avital Perry; Panagiotis Kerezoudis; Nicole M Tombers; Matthew L Carlson; Michael J Link Journal: J Neurol Surg B Skull Base Date: 2018-10-09
Authors: Daniel E Killeen; Anthony M Tolisano; Brandon Isaacson; J Walter Kutz; Samuel Barnett; Zabi Wardak; Jacob B Hunter Journal: J Neurol Surg B Skull Base Date: 2020-10-05
Authors: John P Marinelli; Zane Schnurman; Daniel E Killeen; Ashley M Nassiri; Jacob B Hunter; Katherine A Lees; Christine M Lohse; J Thomas Roland; John G Golfinos; Douglas Kondziolka; Michael J Link; Matthew L Carlson Journal: Neuro Oncol Date: 2022-08-01 Impact factor: 13.029
Authors: Roland Goldbrunner; Michael Weller; Jean Regis; Morten Lund-Johansen; Pantelis Stavrinou; David Reuss; D Gareth Evans; Florence Lefranc; Kita Sallabanda; Andrea Falini; Patrick Axon; Olivier Sterkers; Laura Fariselli; Wolfgang Wick; Joerg-Christian Tonn Journal: Neuro Oncol Date: 2020-01-11 Impact factor: 12.300
Authors: Dominique Valérie Clarence de Jel; Ernst J Smid; Tristan P C van Doormaal; Hans G X M Thomeer Journal: J Int Adv Otol Date: 2021-09 Impact factor: 1.017
Authors: Mayke A Hentschel; Gerjon Hannink; Stefan C A Steens; Jef J S Mulder; Maroeska M Rovers; Henricus P M Kunst Journal: Clin Otolaryngol Date: 2020-11-06 Impact factor: 2.597
Authors: Oliver Profant; Zbyněk Bureš; Zuzana Balogová; Jan Betka; Zdeněk Fík; Martin Chovanec; Jan Voráček Journal: Sci Rep Date: 2021-09-15 Impact factor: 4.379